IDH1105GGT single nucleotide polymorphism improves progression free survival in patients with IDH mutated grade II and III gliomas

Pathology Research and Practice(2021)

Cited 7|Views4
No score
Abstract
•The IDH 1 105GGT SNP can be detected in about 10 % of patients with grade II/ III gliomas.•We investigated the prognostic role of the IDH1 105GGT SNP.•Population on study involved patients with IDH grade II or III mutated glioma.•The presence of IDH1 105GGT SNP was independently associated to a longer progression free survival.
More
Translated text
Key words
D-2-HG,FFPE,EGFR,GBM,HR,IHC,IDH,MGMT,NADPH,OS,PFS,SNP,WHO
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined